Šárka Pospı́šilová
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 87
-
- Lymphoma Diagnosis and Treatment 50
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 27
- Galectins and Cancer Biology 9
- Cancer Research top 2%
- MicroRNA in disease regulation 12
- Oncology top 2%
- Cancer-related Molecular Pathways 32
-
- Advanced Breast Cancer Therapies 13
-
- DNA Repair Mechanisms 9
In The Last Decade
Šárka Pospı́šilová
170 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 124
- Genetics 1.5k
- Pathology and Forensic Medicine 1.0k
- Immunology 1.2k
- Cancer Research 827
- Oncology 1.0k
Countries citing papers authored by Šárka Pospı́šilová
This map shows the geographic impact of Šárka Pospı́šilová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šárka Pospı́šilová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šárka Pospı́šilová more than expected).
Fields of papers citing papers by Šárka Pospı́šilová
This network shows the impact of papers produced by Šárka Pospı́šilová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šárka Pospı́šilová. The network helps show where Šárka Pospı́šilová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Šárka Pospı́šilová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 24 | |
| 13 | 2020 | 22 | |
| 14 | 2019 | 9 | |
| 15 | 2017 | 66 | |
| 16 | 2016 | 116 | |
| 17 | 2015 | 52 | |
| 18 | 2014 | 303 | |
| 19 | 2013 | 82 | |
| 20 | New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis. | 2009 | 0 |
About Šárka Pospı́šilová
Šárka Pospı́šilová is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 181 papers that have together received 4.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (87 papers), Lymphoma Diagnosis and Treatment (50 papers), Cancer-related Molecular Pathways (32 papers), Immunodeficiency and Autoimmune Disorders (27 papers), Advanced Breast Cancer Therapies (13 papers), MicroRNA in disease regulation (12 papers), DNA Repair Mechanisms (9 papers) and Galectins and Cancer Biology (9 papers). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (1.0k citations) and Immunology (1.2k citations). Šárka Pospı́šilová has collaborated with scholars based in Czechia, Germany and Sweden. Frequent co-authors include Marek Mráz, Jiřı́ Mayer, Karla Plevová, Michael Doubek, Boris Tichý, Jitka Malčíková, Karla Malinová, Martin Trbušek, Yvona Brychtová and Šárka Pavlová. Their work appears in journals such as Blood, Leukemia, Haematologica, British Journal of Haematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.